top of page
Frequently asked questions
- 01Four mechanisms. Simultaneously. Every night. DHT Inhibition — Saw Palmetto, Green Tea extract, and Nettle Root extract work at the follicle level to interrupt the conversion of testosterone into DHT, the hormone responsible for follicle miniaturisation. Circulation — Rosemary and Peppermint oil stimulate blood flow at the dermal layer, increasing nutrient delivery directly to the follicle root. Nourishment — Amla and Black Seed provide anti-inflammatory support, conditioning the scalp environment for optimal follicle function. Penetration — Niacinamide acts as the carrier. It ensures all eight active botanicals reach the follicle layer and remain there overnight. No oral intake. No systemic absorption. No hormonal pathway. Find out more about THE ACTIVATOR.
- 02A mild tingling on the first application is normal. It reflects increased circulation at the scalp layer from Peppermint and Rosemary, both at work. It typically settles within the first few nights. If the sensation is uncomfortable or persists beyond the first week, discontinue use and consult a dermatologist.
- 03The formula is topical only. No oral intake. No hormonal pathway. No systemic absorption. The most common experience in early use is mild tingling (see above). The formula is designed for nightly leave-in use on healthy, intact scalp skin. Men with known sensitivities to any listed ingredient should check the ingredients before use. If irritation, redness, or discomfort develops, stop use and consult a dermatologist.
- 04
- 05
- 06
- 07
- 08Men experiencing early hair thinning, specifically: early density loss, visible thinning, or active recession should consider using the serum. It is not formulated for men with advanced or complete follicle loss. Find out through the Apply assessment to confirm whether you are within the intended range.
- 09
- 10Project 120 is Palmetto's 16-week independent clinical study, conducted by Dermatest GmbH in Muenster, Germany, one of Europe's leading dermatological testing institutes. 20 male participants. TrichoScan measurements at Week 0 and Week 16. The study measures objective change in terminal hair density and hair diameter under controlled, supervised conditions. Results are published to members before the general public. Nothing is edited. Full data, positive or negative.
bottom of page